Cooperative Agreement NU2GGH000869

The Department of Health and Human Services' Centers for Disease Control and Prevention awarded a $6,960,000 Cooperative Agreement under the Global AIDS federal grant program (CFDA 93.067) to establish an Integrated Transformational and Sustainable Sample Transport (INTRASSAT) system in Cameroon. The project, led by the Crihss Foundation in collaboration with Georgetown Global Health Nigeria and the Clinical and Laboratory Standards Institute, aims to streamline and modernize Cameroon's...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $11,097,080 to Global Health Systems Solutions (GHSS) to build laboratory capacity and improve the quality of HIV testing services in the Democratic Republic of the Congo (DRC). The key objectives include scaling up quality assurance and improvement for HIV rapid testing and other diagnostic services, implementing quality management systems in diagnostic...

The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $295,963 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to New Health Sciences, Inc. (dba Hemanext Inc.) to evaluate the impact of hypoxic storage conditions on platelet activity in whole blood (WB) for transfusion. The project aims to develop a modernized WB storage platform that maintains low oxygen levels to preserve red blood cell quality and function, while...

This Project Grant award of $160,000 from the Department of State Bureau of African Affairs supports efforts by Adpp Angola under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Programs (CFDA 19.029) to prevent mother-to-child transmission of HIV in Angola. Key deliverables include strengthening HIV care and treatment at health facilities, increasing community engagement, and building clinical laboratory and supply chain infrastructure from August 6, 2021 to September 30, 2021....

This $234,000 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to engineer hemostatic red blood cells (T-RBCs) for the treatment of acute non-compressible hemorrhage. The primary objectives are to: 1) engineer T-RBCs that can bind to collagen and fibrin, 2) test the ability of the T-RBCs to enhance clot formation and stability in vitro, and 3) evaluate the circulation time, clot binding, and...

This $587,500 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS Program (CFDA 93.067) supports efforts by the Cameroon Baptist Convention Health Board to strengthen public health laboratory systems in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) program. The award period runs from October 2024 through September 2027. Key activities include implementing comprehensive HIV services, strengthening laboratory...

This grant from the United States Agency for International Development Haiti (USAID - OM) provided $11,522,969 to DAI Global LLC to implement the Strategic Health Information System (HIS) Program in Haiti from June 2017 through December 2021. The program aimed to improve Haiti's community health information system through consultative services from Thinkmd PBC to review pediatric content and support from Project Balance LLC to transition the Système d'Information Sanitaire National (SISNU)...

This $568,264 Project Grant award (R41HL178144) from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) is supporting SAFI Biotherapeutics Inc.'s efforts to develop a scalable, cost-efficient manufacturing process for producing human red blood cells (RBCs) derived from induced pluripotent stem cells (iPSCs). The goal is to create a renewable source of designer RBCs with specific antigen profiles that can be used as reagents to...

The Centers for Disease Control and Prevention (CDC) awarded a $9,358,205 cooperative agreement (NU2GGH002535) under the Global AIDS program (CFDA 93.067) to the Centre Haitien Pour LE Renforcement DU Systeme De Sante (CHARESS), a non-profit organization based in Haiti. This award aims to strengthen Haiti's healthcare system and achieve HIV epidemic control by 2025. Key products and services to be delivered include: Building the capacity of Haiti's clinical workforce through pre-service and...

This federal Cooperative Agreement award for $6,082,948.00, funded by the Centers for Disease Control and Prevention's (CDC) Global AIDS program (CFDA 93.067), provides technical assistance and support to strengthen the Government of Lesotho's national and district-level HIV and TB programming. The awardee, (Hisp) Health Information Systems Program South Africa, a non-profit organization, will focus on developing and implementing sustainable digital health systems, with an emphasis on data...